Pipeline

Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hor…

Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after…

Two new startups have begun testing their in vivo CAR-T therapies for autoimmune disease in people. China-base…

The protein is implicated in a wide swath of cancers, but harnessing it for drug R&D is still a major scie…

Roche, AstraZeneca and Sanofi demonstrate how companies are following their own R&D paths.…

Dr. Ebrahim Delpassand, founder and CEO of RadioMedix, played a pivotal role in advancing nuclear medicine as …